C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 198-203

  Wen, Jiangping ^a   Liang, Yuanbo ^a,b   Wang, Fenghua ^a   Sun, Lanping ^b   Guo, Yongjun ^a   Duan, Xinrong ^a   Liu, Xiangyi ^a   Wong, Tien Yin ^c,d   Lu, Xinxin ^a   Wang, Ningli ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Handan Eye Hospital   (China)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

C reactive protein; Diabetes mellitus; Gamma glutamyltransferase

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY MASS; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; POPULATION DENSITY; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 72449211517     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.11.002     Document Type: Article

References (32)

1. Pickup J.C., and Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998) 1241-1248
2. Castell J.V., Gomez-Lechon M.J., David M., Fabra R., Trullenque R., and Heinrich P.C. Acute-phase respone of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12 (1990) 1179-1186
3. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 328-334
4. Freeman D.J., Norrie J., Caslake M.J., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51 (2002) 1596-1600
5. Nakanishi S., Yamane K., Kamei N., Okubo M., and Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26 (2003) 2754-2757
6. Thorand B., Baumert J., Kolb H., et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30 (2007) 854-860
7. Hu G., Jousilahti P., Tuomilehto J., Antikainen R., Sundvall J., and Salomaa V. Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. J Clin Endocrinol Metab 94 (2009) 2099-2105
8. Festa A., D'Agostino Jr. R., Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51 (2002) 1131-1137
9. Duncan B.B., Schmidt M.I., Pankow J.S., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52 (2003) 1799-1805
10. Krakoff J., Funahashi T., Stehouwer C.D., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26 (2003) 1745-1751
11. Dehghan A., Kardys I., de Maat M.P., et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56 (2007) 872-878
12. Lee C.C., Adler A.I., Sandhu M.S., et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 52 (2009) 1040-1047
13. Perry I.J., Wannamethee S.G., and Shaper A.G. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 21 (1998) 732-737
14. Lee D.H., Ha M.H., Kim J.H., et al. Gamma-glutamyltransferase and diabetes: a 4 year follow-up study. Diabetologia 46 (2003) 359-364
15. Lee D.H., Jacobs Jr. D.R., Gross M., et al. γ-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49 (2003) 1358-1366
16. Lee D.H., Silventoinen K., Jacobs Jr. D.R., Jousilahti P., and Tuomilehto J. γ-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20, 158 middle-aged men and women. J Clin Endocrinol Metab 89 (2004) 5410-5414
17. Lee D.H., and Jacobs Jr. D.R. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178 (2005) 327-330
18. Tan K.C., Wat N.M., Tam S.C., Janus E.D., Lam T.H., and Lam K.S. C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 26 (2003) 2323-2328
19. Ye X., Franco O.H., Yu Z., et al. Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people. Clin Endocrinol 70 (2009) 854-862
20. Liang Y.B., Friedman D.S., Wong T.Y., et al. Prevalence and causes of low vision and blindness in a rural adult Chinese population: the Handan eye study. Ophthalmology 115 (2008) 1965-1972
21. China Population & Development Research Center. The annual report of Chinese citizen income 2006. Available at: http://www.cpirc.org.cn/tjsj/tjsj_cy_detail.asp?id = 7938. (Accessed March 2006).
22. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
23. Zhou Bei-Fan, and Cooperative Meta-Analysis Group of Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 11 Suppl (2002) S685-S693
24. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
25. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
26. Whitfield J.B. Gamma-glutamyltransferase. Crit Rev Clin Lab Sci 38 (2001) 263-355
27. Drozdz R., Parmentier C., Hachad H., Leroy P., Siest G., and Wellman M. Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 25 (1998) 786-792
28. Paolicchi A., Minotti G., Tonarelli P., et al. Gamma-glutamyltranspeptidase-dependent iron reduction and low density lipoprotein oxidation: a potential mechanism in atherosclerosis. J Investig Med 47 (1999) 151-160
29. Yamada J., Tomiyama H., Yambe M., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189 (2006) 198-205
30. Kerner A., Avizohar O., Sella R., et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25 (2005) 193-197
31. Utzschneider K.M., and Kahn S.E. REVIEW: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91 (2006) 4753-4761
32. Shibata M., Kihara Y., Taguchi M., Tashiro M., and Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30 (2007) 2940-2944